From Nasdaq: 2025-06-10 18:15:00

In the latest trading session, Medpace (MEDP) closed at $305.90, up 2.54% from the previous day, outperforming the S&P 500. Over the past month, MEDP shares have declined by 4.91%, underperforming the Medical sector. Analysts predict an EPS of $2.99 and revenue of $539.75 million for the upcoming earnings release.

The Zacks Consensus Estimates for MEDP’s full-year earnings are $12.71 per share and revenue of $2.18 billion, with year-over-year changes of +0.63% and +3.54%, respectively. Analysts’ estimates can impact stock prices, and MEDP currently holds a Zacks Rank of #3 (Hold). The company has a Forward P/E ratio of 23.47 and a PEG ratio of 5.38.

The Medical Services industry, to which MEDP belongs, has a Zacks Industry Rank of 70, placing it in the top 29% of industries. The top 50% of Zacks Industry Ranked industries outperform the bottom half by a ratio of 2 to 1. Stay updated on these metrics and more on Zacks.com for informed investment decisions.

For just $1, access all Zacks’ Buys and Sells to explore investment opportunities. Discover portfolio services like Surprise Trader and Technology Innovators that closed 256 positions with double- and triple-digit gains in 2024. Thousands have taken advantage of this offer, and you can too. Get acquainted with Zacks Investment Research for the latest recommendations and insights.



Read more at Nasdaq: Medpace (MEDP) Exceeds Market Returns: Some Facts to Consider